Novel Pharmacological Treatment of Post-prandial Hyperinsulinemic Hypoglycemia

Emily Cooper
Additional contact information
Emily Cooper: Diabesity Institute, USA

Current Research in Diabetes & Obesity Journal, 2019, vol. 10, issue 1, 6-9

Abstract: Background: Post Roux-en-Y gastric bypass (RYGB) hyperinsulinemia hypoglycemia (HH) is presumably related to enhanced glucagon-like peptide-1 (GLP-1) response with partial pancreatectomy as recommended treatment. A new approach successfully uses short-acting GLP-1 mimetics, challenging assumptions about post-RYGB HH etiology and standard treatment.

Keywords: juniper publishers; diabetes journals; diabetes impact factor; endocrinology journal; endocrinology impact factor; endocrinology research journal; endocrinology research articles; diabetes open access journals; Obesity Journal; Diabetes & Obesity Journal (search for similar items in EconPapers)
Date: 2019
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/crdoj/pdf/CRDOJ.MS.ID.555777.pdf (application/pdf)
https://juniperpublishers.com/crdoj/CRDOJ.MS.ID.555777.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:jcrdoj:v:10:y:2019:i:1:p:6-9

DOI: 10.19080/CRDOJ.2019.10.555777

Access Statistics for this article

Current Research in Diabetes & Obesity Journal is currently edited by Sophia Mathis

More articles in Current Research in Diabetes & Obesity Journal from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().